Authors' Reply to Schoenfeld: "Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors"

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/24301

Title:	Authors' Reply to Schoenfeld: "Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors"
Authors:	Michiels, Stefan Saad, Everardo D. BUYSE, Marc
Issue Date:	2017
Publisher:	ADIS INT LTD
Source:	DRUGS, 77(10), p. 1139-1140
Notes:	[Michiels, Stefan] Gustave Roussy, Serv Biostat & Epidemiol, F-94805 Villejuif, France. [Michiels, Stefan] Univ Paris Sud, Univ Paris Saclay, UVSQ, CESP,INSERM,U1018, F-94805 Villejuif, France. [Michiels, Stefan] Gustave Roussy, Ligue Natl Canc Metaanal Platform, F-94805 Villejuif, France. [Saad, Everardo D.] IDDI, Louvain La Neuve, Belgium. [Buyse, Marc] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Hasselt, Belgium. [Buyse, Marc] IDDI, San Francisco, CA USA.
Document URI:	http://hdl.handle.net/1942/24301
ISSN:	0012-6667
e-ISSN:	1179-1950
DOI:	10.1007/s40265-017-0761-x
ISI #:	000403591800011
Rights:	© Springer International Publishing Switzerland 2017
Category:	A1
Type:	Journal Contribution
Validations:	ecoom 2018
Appears in Collections:	Research publications

File	Description	Size	Format
michiels2017.pdf Restricted Access	Published version	381.98 kB	Adobe PDF	View/Open Request a copy

Check